Detalhe da pesquisa
1.
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins.
Nat Immunol
; 18(4): 464-473, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28192418
2.
Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing.
J Am Chem Soc
; 140(21): 6596-6603, 2018 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29668265
3.
Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.
PLoS Pathog
; 12(4): e1005578, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27081859
4.
Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From Bats.
J Infect Dis
; 215(2): 209-213, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27811320
5.
Induction of Broadly Cross-Reactive Stalk-Specific Antibody Responses to Influenza Group 1 and Group 2 Hemagglutinins by Natural H7N9 Virus Infection in Humans.
J Infect Dis
; 215(4): 518-528, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28380622
6.
Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
J Virol
; 90(2): 851-61, 2016 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512088
7.
Hemagglutinin Receptor Binding of a Human Isolate of Influenza A(H10N8) Virus.
Emerg Infect Dis
; 21(7): 1197-201, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26079843
8.
H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge.
J Virol
; 88(4): 2340-3, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24307585
9.
Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans.
J Virol
; 88(22): 13260-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25210189
10.
Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples.
medRxiv
; 2021 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532798
11.
Robotic RNA extraction for SARS-CoV-2 surveillance using saliva samples.
PLoS One
; 16(8): e0255690, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351984
12.
LuNER: Multiplexed SARS-CoV-2 detection in clinical swab and wastewater samples.
PLoS One
; 16(11): e0258263, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34758033
13.
Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus.
PLoS One
; 16(5): e0251296, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34038425
14.
IGI-LuNER: single-well multiplexed RT-qPCR test for SARS-CoV-2.
medRxiv
; 2020 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33330883
15.
A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice.
NPJ Vaccines
; 12016.
Artigo
em Inglês
| MEDLINE | ID: mdl-29250436
16.
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
Cell Host Microbe
; 19(6): 800-13, 2016 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27281570
17.
Multifaceted biological insights from a draft genome sequence of the tobacco hornworm moth, Manduca sexta.
Insect Biochem Mol Biol
; 76: 118-147, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27522922
18.
An H10N8 influenza virus vaccine strain and mouse challenge model based on the human isolate A/Jiangxi-Donghu/346/13.
Vaccine
; 33(9): 1102-6, 2015 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25604801
19.
Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.
Vaccine
; 33(29): 3314-21, 2015 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26026378
20.
Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
mBio
; 6(2): e02556, 2015 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25759506